Sitravatinib

Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and Axl.

Price Not Available 200 mg Sitravatinib Supplier Page

Catalog Number	T4349
Alternative Name(s)	MG516 , MGCD516
Research Area	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis
Molecular Formula	C33H29F2N5O4S
CAS#	1123837-84-2
Purity	98.90%
SMILES	COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
Size	200 mg
Supplier Page	https://www.targetmol.com/compound/Sitravatinib
Additional Information	https://www.targetmol.com/datasheet/T4349